James Parsons's Insider Trades & SAST Disclosures
James Parsons's most recent trade in City Holding Co. was a trade of 2,200 Common Stock done at an average price of $122.4 . Disclosure was reported to the exchange on May 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Parsons.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| City Holding Co. | James M. Parsons | Director | Purchase of securities on an exchange or from another person at price $ 122.38 per share. | 12 May 2025 | 2,200 | 2,700 (0%) | 0% | 122.4 | 269,225 | Common Stock |
| City Holding Co. | James M. Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 266 | 266 (0%) | 0% | 0 | Common Stock | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 5.34 per share. | 02 Jan 2025 | 15,917 | 75,854 (0%) | 0% | 5.3 | 84,997 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 4,287 | 4,287 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 28,472 | 28,472 | - | - | Stock Option (right to buy) | |
| City Holding Co. | James M. Parsons | Director | Purchase of securities on an exchange or from another person at price $ 102.10 per share. | 30 May 2024 | 400 | 500 (0%) | 0% | 102.1 | 40,842 | Common Stock |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 2.80 per share. | 02 Jan 2024 | 21,428 | 59,937 (0%) | 0% | 2.8 | 59,998 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 16,968 | 16,968 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,222 | 13,222 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 3.58 per share. | 03 Jan 2022 | 16,773 | 38,509 (0%) | 0% | 3.6 | 60,047 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 9,393 | 9,393 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 8.23 per share. | 01 Jan 2021 | 7,745 | 21,947 (0%) | 0% | 8.2 | 63,741 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 13,306 | 13,306 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 4.59 per share. | 01 Jun 2020 | 8,102 | 14,202 (0%) | 0% | 4.6 | 37,188 | Voting Common Shares, no par value per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges